Professional Documents
Culture Documents
896.DEL.2002 Intermed Labs
896.DEL.2002 Intermed Labs
896.DEL.2002 Intermed Labs
MWW
ffiw%.
3:i:
GOVBRNMENT OF INDIA
PA'I-BN'I' OFFICE,, DELHI BRANCH MINISTRY OF COMMERCE & INDUSTRY
S E C - 1 , 1 ,D W A R K A NEW DEI,HI - I IO078 clc. \o. 2803,1J04-0622 ,
|l"lTtl.L.ttJl"UhL. ??"{}?L?,TYeW&WUe
No.
To, Natraj& Associates, M/S Subramaniam, -AT-LAW ATTORNEYS Agents, Patent& Trademarks N K E- 5 5 5G r ea te r a i l a sh ,l l , e w D elhi,110048 , U/ R S u b i e c t : e p r e s e n t a t i o n S2 5 ( 1 )f i l e db v M reg , o n 1 8 / 0 9/20 0 8D eci si o n a rdine/S i r /M a d a m ,
, _ it,l
l n t e r m e dL a b s .P v t . L t d ,
and heari
- - - - - - -
- - - - - - - d _ _ _ - i - - '
N i B a n s a l o r e(,K S ) n r e s p e c to f A p p l i c a t i o n o 896/Del/2
aboveand find as refe rto the repr esentation m entioned P l e a se . of in the e n c l o s ed D eci si o nda te d3 0/0712009 r espect saidr epr esentation , T h a n k i ny o u , g
1
i
t\ r''"
(HARDEV KARAR) & OF (ASSTT. CONTROLLER PATENTS DFSIGNS) NEWDELHI OFFICE, PATENT
C o p yt o :
Elecon and 1. M/s S. Majumdarand Co.,Patent TrademarksAttorneys,2oZ, M 400072, .S. B C h a m b e rs, e h i ndS akiN a ka ,M um bai,
O , l & o 2 . S h .p . K . p a t n iJ t . C o n t r o l l e r f P a t e n t s D e s i g n sI,n t e l l e c t u aP r o p e r t y f f i c e ,N e w D e l h i . O l , l 3 T h eT e c h n i c ah e a d ,P a t e n t s I n t e l l e c t u aP r o p e r t y f f i c e ,N e w D e l h i f o r n . a '
I. , " i
'l_r{-.
;'.
The Patentsact, 1970 (amended the patentsact 2005) by AND THEPATENT RULES, 2OO3 (Amended the PatentRules by 2006) ln the matterof patentApplication 896/DEL/2002, on o4-og-zoo2 no. filed (Divisional of out Application prioritydatedzS/O7l1,gg7) No.2I74/Del/1998 dated24-07-LggB UnitedStates & AND l n t h e m a t t e ro f r e p r e s e n t a t i o n w a y o f o p p o s i t in l J / s2 5 ( 1 )d a t e d2 7 t h o v e m b e2 0 0 7o n by o N r s a i da p p l i c a t i oN o . 8 9 6 /D E L2 0 0 2 . n / The Applicants M / s G I L E A S C I E N C E N , o f 3 3 3 L a k e i d eD r i v e F o s t e C i t yC a l i f o r n i a 9 4 4 0U , i t e d t a t e s f D ISC s , r 4n S o America. The opponents M / s l n t e r m e dL a b sP v t . L t d , h a v i n gi t s r e g i s t e r e a d d r e s s t 7 7 K I A D B n d u s t r i aA r e a ,J i g a n i , d a I l Bangalore, 5621,06, Karnataka, India..,
Present: S h H . S u b r a m a n i a mS h .G . N a t r a j ,D r . R i t u G a n d h io f M / s S u b r a m a n i a mN a t r a j& A s s o c i a t e s , , , N e w D e l h i ,I n d i a . . . . . . . . . . . . . . . . . . . A t t o r n ef o r t h e A p p l i c a n t . ys s h . s . M a j u m d a ro f M / s M a j u m d a r & C o . ,K o l k a t a . . . . . . . . . . . A t t o r nfe y sh e o p p o n e n t or t
Hearing held on September 18tn, 2008 DECtSION ( A )A n o p p o s i t i o w a sf i l e du n d e rs e c t i o n 5 ( 1 )a g a i n stth e g r a n to f P a t e n t o a p p l i c a t i o n n 2 n o .8 9 6 / D e l / 2 O O 2 2 7 t n o v e m b e 2 0 0 7 . on N r T h e b i b l i o g r a 5 i h i n d e v e n td e t a l l s f t h e p a t e n ta p p l i c a t i o a n d o p p o s i t i o n / s 2 5 ( 1 ) a r e ac o n U mentioned elow: b Item Details D a t eo f a p p l i c a t i o n 04.09.2002 ,antedatedto the date of filing the parent application o. 2flalDell1,998 N dated 24.O7.1998 United States priority & date 25/07 /1997 D a t eo f P r i o r i t y f t h e a p p l i c a t i o n o 251071L997 (priority from the U.S. applications)
3.
T i t l eo f t h e a p p l i c a t i o n
4.
5.
R
) B I S( P O C P M P Ai s a p r o m i s i n g g e n tf o r t h e a t r e a t m e n ta n d P r o p h y l a x io f H I V a n d o t h e r s v i r a li n f e c t i o n s . p u b l i c a t i o n n t h e o f f i c i a l 2l-" Jan2005 Date of i journal D a t eo f i s s u a n co f F i r s tE x a m i n a t i o n3 0 ' "M a y 2 0 0 6 e report L a s t d a t e o f c o m p l i a n c e f a l l t h e 30thMay 2007 o objections Date of submission of finallv @ amendedlaims. c
D a t e o f f i l i n g o f t h e R e p r e s e n t a t i o n 27thNovember 2OO7 b y t h e a b o v en a m e d p a r t y D a t eo f r e p l yb y t h e a p p l i c a n t L 6 i i l M a y2 0 0 8 D a t e o f h e a r i n go f t h e p [ a r t i e sb y t h e 1*FS"p2oos Controller E v i d e n c ef i l e d b y t h e o p p o n e n t s E v i d e n c ef i l e d b y t h e A p p l i c a n t s
7. B. 9. 10.
r".
L2. 13.
( B )T h e o p p o n e n t s p p o s e dt h e G r a n t o f p a t e n t su n d e r s e c t i o n2 5 ( 1 ) , o n t h e g r o u n d s o m e n t i o n e d e l o w :b
a . T h a t t h e i n v e n t i o ns o f a r a s c l a i m e di n a n y c l a i m o f t h e c o m p l e t e s p e c i f i c a t i o n w a s p u b l i c l y k n o w n o r p u b l i c l yu s e d i n I n d i a b e f o r e t h e p r i o r i t y d a t e o f t h a t claim. b . T h a t t h e i n v e n t i o ns o f a r a s c l a i m e di n a n y c l a i m o f t h e c o m p l e t e s p e c i f i c a t i o ns i p c l a i m e d i n a c l a i m o f a c o m p l e t e s p e c i f i c a t i o n u b l i s h e do n o r a f t e r t h e p r i o r i t y d a t e o f t h e a p p l i c a n t ' s l a i ma n d f i l e d i n p u r s u a n c e f a n a p p l i c a t i o no r a p a t e n t c o f i n l n d i a , b e i n g a c l a i m o f w h i c h t h e p r i o r i t yd a t e i s e a r l i e rt h a n t h e a p p l i c a n t ' s claim. c . T h a t t h e i n v e n t i o ns o f a r a s c l a i m e di n a n y c l a i m o f t h e c o m p l e t e s p e c i f i c a t i o ns i o b v i o u s a n d c l e a r l y d o e s n o t i n v o l v e a n y i n v e n t i v es t e p , h a v i n g r e g a r d t o t h e
( m a t t e rp u b l i s h e d s m e n t i o n e dn c l a u s e a ) o r h a v i n g e g a r d o w h a t w a s u s e d a i r t i n I n d i ab e f o r e h e p r i o r i t y a t eo f t h e a p p l i c a n t 'c l a i m . t d s d . T h a t t h e i n v e n t i o n o f a r a s c l a i m e d n a n y c l a i mo f t h e c o m p l e t e p e c i f i c a t i o n s i s h a sb e e np u b l i s h e d e f o r e h e p r i o r i t y a t eo f t h e c l a i m . b t d 1 . I n a n ys p e c i f i c a t i oine di n p u r s u a n co f a n a p p l i c a t i o n r a p a t e n tm a d ei n I n d i a n o r e f l fo o afterthe l-" day of January, L9I2; or 2 . l n I n d i a r ' e l s e w h e r en a n yo t h e rd o c u m e n t s : o i, e . T h a t t h e s u b j e c to f a n y c l a i m o f t h e c o m p l e t es p e c i f i c a t i oin n o t i n v e n t i o n s e w i t h i nt h e m e a n i n g f t h i sA c t ,o r i s n o t p a t e n t a b l u n d e r t h i s c t ; o A t . T h a t t h e c o m p l e t es p e c i f i c a t i od o e s n o t s u f f i c i e n t l a n d c l e a r l y e s c r i b eh e n y d t i n v e n t i o n r t h e m e t h o db y w h i c hi t i s t o b e p e r f o r m e d . o g . T h e a p p l i c a nh a sf a i l e d o d i s c l o ste t h e C o n t r o l l etrh e i n f o r m a t i o ne q r . r i r e d t t o r by r S e c t i o n o r h a sf u r n i s h e dh e i n f o r m a t i o n h i c hi n a n y m a t e r i a p a r t i c u l aw a s B t w l f a l s e o h i sk n o w l e d g e . t (C) The initially filed cloims are reproduced below (Total 22) 1 . A c o m p o s i t i oo f f o r m u l a( 1 ) n
7 . A c o m p o s i t i o n o m p r i s i n g l i t h i u ma l k o x i d e n d a 9 - ( 2 h y d r o x y p r o p y l a d e n i n e c a a ) solution. 8 . A c o m p o s i t i o c o m p r o s i n a n ( R ,S ) - P M P s o l u t i o n t a p H o f a b o u t2 . 7 - 3 . 5 h e r e i n n g A a w t h e s o l u t i o n a sl e s s h a n a b o u t0 . 1 , g / m( R ,S ) -P M P Aa n d w h e r e i n b o u t9 0 - 9 4 % o f h t l a t h e P M P A s i n t h e ( R )c o n f i g u r a t i o n . i 9 . A m e t h o dc o m p r i s i n o r a l l ya d m i n i s t e r i n g a p a t i e n ti n f e c t e d i t h v i r u so r a t r i s k g to w t o v i r a li n f e c t e d t h e r a p e u t i c a ley f e c t i v e m o u n to f a c o m p o s i t i oo f c l a i ml - . a lf a n 1 0 "A m e t h o dc o m p r i s i nc o n t a c t i n b i s( P O CP M P A i t h f u m a r i c c i d . ) g g w a 1 1 .T h em e t h o do f c l a i m1 0 w h e r e i n h e f u m a r i c c i di s d i s s o l v e id 2 - p r o p a n o , . t a n 1 2 .A m e t h o dc o m p r i s i n g i x i n ga l i t h i u ma l k o x i d e i t h a 9 - ( 2 - h y d r o x y p r o pa d)e n i n e m w yl solution. 1 3 .T h e m e t h o do f c l a i m1 2 w h e r e i nt h e l i t h i u ma l k o x i d es a n a l k o x i d e e l e c t e do r m i s f t h e g r o u pc o n s i s t i no f m e t h o x i d ee t h o x i d en - p r o p o x i d e ,- p r o p o x i d e ,- b u t o x i d e , g , , z n z - b u t o x i d e , b u t o x i d e n e o p e n t o x i d e ,- p e n t o x i d e- p e n t o x i d e r n - h e p t o x i d e ,f, n o n /, h e p t o x i d e , - h e p t o x i d e ,- o c t o x i d e ,- o c t o x i d ey p i c a l l y ^ - b u t o x io r z - p r o p o x i d e . 2 n 2 t, de 1 4 .T h e m e t h o do f c l a i m1 3 w h e r e i n h e l i t h i u ma l k o x i d es l i t h i u mf - b u t o x i d e r l i t h i u m t i o i-propoxide. 1 - 5A m e t h o dc o m p r i s i n a d j u s t i n t h e p H o f a s o l u t i o n o m p r i s i n lg s s h a n a b o u t0 . 0 8 . g g c e t g / m l ( R , S ) - P M P A w h e r e ib o u t9 0 - 9 4 % f t h e P M P Ai s i n t h e ( R )c o n f i g u r a t i oo f a an o n p H o f a b o u t2 . 7 - 3 . 5 . L 6 .A c o m p o s i t i o c o m p r i s i n a t a b l e tc o n t a i n i n 9 - [ 2 - ( R ) - [ B l S [ ( i s o p r o p o x y c a r b o n y ) n g g oxy] p h o p h i n o y l m e t h o x y lp r o p y l l a d e n i n e *f u m a r i ca c i d ( 1 - : 1 )p r e g e l a t i n i z e d a r c h , l , st c r o s c a r m e l l o s o d i u m l,a c t o s e o n o h y d r a ta n d m a g n e s i u mt e a r a t e . e m e s 1 7 .T h e c o m p o s i t i o o f c l a i m1 6 w h e r e i n h e 9 - [ 2 - (R ) - [ b i s [ ( i s o p r o py c a r b o n y l ) x y ] n t o ox m e t h o x y p h o s p h i n o y l e t h o x y p r o p y l l - a d e n i n e - f u m a r i ic ( 1 : 1 )i s c r y s t a l l i n e . l m l ac d 1 - 8T h e c o m p o s i t i o no f c l a i m 1 6 w h e r e i n t h e t a b l e t c o n t a i n s 7 5 m g 9 - [ 2 - ( R ) . I b i s [ [ ( i s o p r o p o xc a r b o n y ) o v y ] m e t h o x y l p h o s p h i n o y l l m e t h o x y l p r o p h y l y f a d e n i n e > >u m a r i ca c i d ( 1 : 1 ) ,1 1 m g p r e g e l a t i n i z e d a r c h ,B . B m g r o s c a r m e l l o s e st c s o d i u m L 2 3 . 6 g l a c t o s e o n o h y d r a ta n d 2 . 2m g m a g n e s i u mt e a r a t e . , m m e s 1 9 .A p r o d u c t p r o d u c e db t t h e p r o c e s s f p r e p a r i n g e t g r a n u l e s r o m a m i x t u r e o w f s c o m p r i s i n g l i q u i d 9 - t 2 - ( R ) - t t b i( i s o p r o p o x y c a r b o n y ) o x y lt h o x y lp h o s p h i n o y l a me ) l y m e t h o x y lp r o p y l l- a d e n i n e f u m a d ea c i d( ! : 1 -a n d a p h a r m a c e u t i c a al c c e p t a b l e excipient.
e):
' L . A n u c l 6 o t i da n a l o g f f o r m u l a 1 ) . ( e o
v*Ln'l-l* & r r 8 o
0)
9 . A C o m p o s i t i o n o m p r i s i n g l i t h i u m a l k o x i d e n d 9 - i 2 - h y d r o o x y p r o p y ld e n i n e c a a a) n s o l u t i o no r t h e p r e p a r a t i o o f P M P A u c ha s h e r e i n e s c r i b e d . f s d
(E) The opposition will be examined in the light of the smended claims. Both the porties were heord at length on 78'hSeptember, 2008. The grounds of Novelty (Seeporo B.d above), insufficient disclosure (SeeB.f) above), prior public use/ prior public knowledge (see B.a. above) ond the information required by Section8 (seeB.g above) withdrawn by opponent on the doy of hearing.
(F) Discussion obout the grounds of Opposition: (F.7) Ground of Prior Cloiming) O n c a r e f u c o n s i d e r a t i oo f t h e a r g u m e n t o f b o t h t h e p a r t i e s e l a t i n go t h i s g r o u n dI l n s r t f o u n dt h a t t h e r ew a s n o c l e a rs u p p o r t n t h e U n i t e d t a t e s r i o r i t y o c u m e n t r e l a t i n go D 1 i p S d s t i . e .( 2 0 7 6 / D e l / 1 . 9 9o r m a i n t a i n i n p r i o r i t y f B P P FB i s( P O C P M P AF u m a r a t ef ) o m d a t e ( f 7) g ) o r 2 5 1 0 7 1 1 9 9I6 .a b s e n c e f w h i c h , h e p r i o r i t yf o r B I S P O CP M P AF u m a r a t e a nn o t s a i dt o n ( ) o t c be existedfrom 26/0711.996 inferredby the opponents as from the wordingsof claim t-, c l a i m3 1 a n dd e s c r i p t i oin s p e c i f i c a t i o n D L o n p a g e2 , 4 1 , n d4 7 . n of a T h e r e f o r eh e p r i o r i t y o r t h e d i s c l o s u ro f s a i dB P P F D 1 -e x i s t s r o m 2 5 l 0 7 l t g g l w h i c hi s ( ) t f e f e q u i v a l e nt to t h e d a t e o f p r i o r i t yf o r t h e i m p u g n e d p p l i c a t i o N o . 8 9 6 / D e l l 2 O 0i2e . a n . 2 5 / 0 7 1 1 9 9 7 . e r e f o r e 1 i n a d d j t i o n o i t ' s p r i o r i t i e f a i l t o e s t a b l i s t h e g r o u n do f p r i o r Th s D t h claiming.
( F . 2 ) I n v e n t i v e s t e p : O p p o n e n t r e l i e d n f o l l o w i n g r i o ra r t d o c u m e n t t o c h a l l e n gte e p s o s h i n v e n t i vs t e po f t h e i n v e n t i o a sc l a i m e dn t h e i m p u g n e a p p l i c a t i o n : e n i d
( F . 2 . IP r i o r r t d o c u m e n t s : 1 a
( i ) B i s( P O CP M P Aa n o r a l l yb i o a v a i l a b l p r o d r u go f t h e a n t i r e t r o v i r aa g e n tP M P A C o n f , ) e l , Retroviruses opportunistic infect 1997,Jan.22-26,4rH (Abstract LOA no.21,4), Bischogberger d e t . A l . ,p u b l i s h e o n 2 2 - 2 6 / 0 1 , 1 1 , 9 9 8 e x e d s D 2 ( h e r e i n a f t e r 2 ) . ann a D
( i i )S a l ts e l e c t i o n r b a s i c r u g ,I n t e r n a t i o n a l j o u r nfa lr p h a r m a c e u t i c3 3 ( 1 9 8 6 )2 1 , O - 2 I 7 , s, , o o d G o u l d t .A l .a n n e x e d sD 3 ( h e r e i n a f t e r 3 ) ; e D a ( i i i )M a t e r i a s a f e t yd a t a s h e e t s o r c i t r i ca c i da n d f u m a r i ca c i d ,a n n e x e d s D 4 ( h e r e i n a f t e r l f a D4) ( i v )P h a r m a c e u t i cs a l t s , . l o u r n a lf p h a r m a c e u t i cs c i e n c e s ,a n .1 9 9 7 ,v o l . 6 6 N u m b e r1 , al al o J B e r g e t . A l J a n! 9 7 7 , a n n e x e d s D . 5( h e r e i n a f t e r 5 ) . D e a (v)CA2L26601, (hereinafter annexed D6 dated30/12/1.994 as D6). ( v i )U S5 4 9 8 4 L 9 a r c hL 2 , 1 9 9 6 n n e x e d s D 7 ( h e r e i n f t e rD 7 ) . M a a a (vii)US5994387 DB). annexed DB(hereinafter as dated21,.'J,1,.96
( F . 2 . 2 .T h e o p p o " n e n th a v e p r e s e n t e d a r i o u s o m b i n a t i o no f t h e d o c u m e n t so e s t a b l i s h ) s v c s t o b v i o u s n e s s t h e c l a i m e dn v e n t i o nT h es a m ei s d e p i c t e d s u n d e r : i . of a
1 , . D 2a l o n e 2 . D z+ D r 3. Dz+Ds
4. D2+D6 5. D3+D6 6. D2+D5+D6 7. D7+Dg B. D2+D,+Po. 9 . D 6a l o n e l - 0 .D za l o n e l - 1 .D s a l o n e 1-2. D2+D5+D6 1-3. D2+Dt 1"4. D2+D3+D7 L5.D2+D5+D7 L6.D2+D5+Pt
( F . 2 . 3 ) h e i m p u n g n e d n v e n t i o ni s d e d i c a t e do s o l v et h e p r o b l e mo f u n s t a b i l i t y n d l o w T i t a ) b i o a v a i l a b i l ioy B i s( P O C P M P A( w h i c hi s k n o w na n t i v i r aa c t i v es u b s t a n c e f o r a l l yi n g e s t e d . tf l i) T h i sp r o b l e mh a v eb e e ns o l v e d y p r o v i d i n g u m a r a t s a l to f B i s( P O Cp M p A ,t h e B p p F . ) b F e ( F . 2 . 4 . l . lh a so b s e r v e dh a t D 2d i s c l o s ets e a c t i v ea g e n tB i s( P O C P M P Ab e f o r et h e p r i o r i t y t t ) h d a t eo f i m p u n g n ea p p l i c a t i o n . d ( F . 2 . 5 .F u r t h e r 3p r o v i d e s r a t i o n a l eo s a l ts e l e c t i o f o r b a s i c r u g s P a g e p r o v i d e s t a b l e ) D a t n D . 2 a 'FDA " S A L T O R M Sw h i c h l i s t " F u m a r a t e a s a p o s s i b l e a l t f o r m u s e di n O . 2 5 % f t h e b a s i c F " s o D r u gm a r k e t e di l l I 9 7 4 . f h e d o c u m e n t s l s od i s c l o s e s e r e a s o n o r s e l e c t i o n f v a r i o u s a l t s t a th f o s i n c l u d i n g u m a r a t e a l t s .T h e s e s a l t s p r e p a r a t i o n o f p h a r m a c e u t i c a lay t i v e c o m p o u n d s F s s lc d e v e l o ph e i m p r o v e d r o p e r t i e s u c ha s i m p r o v e d i o a v a i l a b i l ia y d t h e e n h a n c e d t a b i l i t yI. p t B tn s o b s e r v e r o m t h e d i s c l o s u r o f D 3t h a t t h e d i s c l o s u ro f D 2a n d D 3w o u l d m o t i v a t e p e r s o n f e e a s k i l l e dn t h e a r t t b d e v e l o p n a c i da d d i t i o n a l ti n c l u d i ntg e F u m a r a ts a l t . i a s h e ( F . 2 . 5 ) o b s e r v e d t h a t t h e d o c u m e n tD 6 d i s c l o s ets e p h a r m a c e u t i c a lc c e p t a b l e a l t so f l h s phosphonate ucleotide ster derivatives, hich can be orally administered nd used as n e w a a n t i v i r aa g e n t sT h e b a s i c r u gm o l e c u l e s e di n D 6i n c l u d e M E A( 9 - ( 2 - p h o s p h o n y l m e t h o x y ) l . D u P e t h y la d e n i n e ) . h e p r o b l e ms o l v e d n t h e d o c u m e n t 6 i f o f d e f i c i e n co f o r a l a b s o r p t i v i to f T i D y y t h e a c t i v e o m p o u n dT h ec o m p o u n d b e i n gu s e di n t h e D 6a r e h a v i n g l o s e t r u c t u r a l r o x i m i t y c . s p c s w i t h t h e p a r e n t ac o m p o u n d s f i m p u n g n e dn v e n t i o n n d b o t h a r e u s e di n t h e e s t e rf o r m s . l o i a T h e r e f o r e h e s k i l l e dp e r s o n w o u l d e x p e c tt o a c h i e v es u c c e s s o r a c t i v e c o m p o u n d s f t f o i m p u g n e id v e n t i o n . n D 6o n p a g e6 o f s p e c i f i c a t i o n s c l o s ee x a m p l e o f s a l t s n c l u d i n gu m a r a t e w h i c hw e r e f o u n d di s s i f , s u i t a b 1f6 r m a k i n g a l tw i t h t h e p a r e n t ac o m p o u n dfs r o b t a i n i n gh e d e s i r e d h a r m a c e u t i c a l o l s o p t p r o p e r t i e s . h e r e f o r eh e d i s c l o s u r o f D 6 p r o v i d e s u f f i c i e n m o t i v a t i o n n d e x p e c t a t i o o f T t e s t a n s u c c e s so a p p l y i t s t e a c h i n g s o t h e f o r m a t i o no f a F u m a r a t e a l t o f t h e c o m p o u n do f t t s i m p u g n e d p p l i c a t i ow i t h s u p e r i o p h y s i c a l r o p e r t i eo v e ra f r e e b a s e . p s a n r ( F . 2 . 7 . 1 7 d i s c l o s e t h a t t h e F u m a r a t e a l t o f 4 ( d i e t h y l1 - - 3( L - m e t h y l o c t y l - B , 9 , 1 0 D s 7 s t e t r a p h y d r 0 - 6 , 9 ,t9 i m e t h y 6 H d i b e n z o b , d ] p y r a n - L - 0 1 ,d i,m e t h y a m i n o b u t y r ia c i de s t e ri s 4 r l l c [ f o u n ds u r p r i s i n g sy a b l e n o n h y d r o s c o p ic r,y s t a l l i n e , a b l e v e r p r o l o n g e d e r i o d s f s t o r a g e lt , c p st o o
a t R T . T h i s d o c u m e n t i n d i c a t e st h a t F u m a r a t es a l t s a r e m o r e a p p r o p r i a t e o u s e a s t p h a r m a c e u t i ca g e n tu n l i k e t h e rk n o w ns a l t s . al o ( F . 2 . 8 .T h e a p p l i c a n tc o n t e n t i o n i n v i e w o f t h e c i t a t i o n s s d i s c u s s ea b o v ef o r e v a l u a t i n g ) ( s a d o b v i o u s n e s s d i n v e n t i v e n e s s d a l s oi n v i e w o f t h e O p p o n e n t se l i a n c e n t h e d e c i s i o n f an an r o o U n i t e d t a t e s o u r t so f A p p e a l so r t h e f e d e r a c i r c u i t sn P f i z e rI N CV s A p o t e xt N C( 2 0 0 6 - 1 2 6 1 ) S c f l i d e c i d e d n M a r c h2 2 , 2 0 0 7w h e r et h e H o n ' b l e o u r th a sd e f i n e d h a t i s " U n e x p e c t es u p e r i o r o d C w p r o p e r t ya n d " R e a s o n a b pe o b a b i l i to f S u c c e s si"s t h a t : ' lr y ) i . T h e d o c u m e n t sr e l i e d u p o n a n d c o m b i n e db y t h e o p p o n e n t sf o r e v a l u a t i n gh e t o b v i o u s n e s sn d i n v e n t i v e t e po f t h e i m p u g n e d p p l i c a t i o a r e n o t a p p r o p r i a t a s a s a n e t h e F u m a r a t e a l t sa s m e n t i o n e d n v a r i o u s o c u m e n t s i s c u s s ea b o v ea r e m e r e s i d d d l i s t i n g f t h e s a m ea l o n gw i t h o t h e r sl i k eC i t r a t eT a r t a r a t eM a l a t ee t c .a n dt h i sd o e s o , , n o t i n d i c a t eh a t b y c o n s i d e r i ntg e s a m ea s p r i o ra r t n o s k i l l e d e r s o n n e x p e c t e d t p h i t o a r r i v e t t h e s u c c e sts c a r r yo u t t h e i n v e n t i o n ; a o 'The ii. r e s u l ti n t h e i m p r o v e m e no f p r o p e r t i e o f B i s( P O C P M P Aw e r e n o t e x p e c t e d o s ) t s w i t h f u m a r a t es a l t a n d t h e s u c c e s w a s n o t e x p e c t e d e c a u s e f t h e r e a s o na s s b o d e t a i l e di n t h e e x p e r te v i d e n c e y D r . S u n d r aM o o r t h i s w a m i n a t h a n n d b v t h e b a h a p p l i c a nitn p a r a g r a p 8 . 4 1o f r e p l ys t a t e m e n t . T h e e x p e r t e v i d e n c e y D r S u n d r aM o o r t h i h a s d e t a i l e du n e x p e c t e d e s u l t si n h i s e x p e r t b r e v i d e n c e n dt h e r e b y h e a p p l i c a n ts t a t e s h a t F u m a r a t e a l to f B i s( P O CP M P A e h a v e dn a n a ) t s t s b i u n e x p e c t em a n n e ra n d e x h i b i t e d u r p r i s i n p r o p e r t i e w h i c hw e r e n o t w i t h i nt h e p e r c e p t i o n d s s g o f t h e p e r s o n k i l l e dn t h e a r t . i s I t i s s t a t e db y t h e m t h a t i t w a s e x p e c t e dh a t f u m a r i c c i dw o u l d b e a s u i t a b l e o u n t e ri o n f o r t a c ) B i s( P O C P M P Al e a d i n g o a s t a b l ea n d u s e f u l o m p o u n dT h e r ew e r e n o n u c l e o t i d e r o d r u g t c . p t h a t w e r ea v a i l a b lo r a p p r o v e d y F D A t t h e t i m e o f i n v e n t i o n f t h e B P P F . e b a o ( F . 2 . 9 . ) o w e v e ro n p e r u s a lo f t h e j u d g m e n ta s r e f e r r e da b o v e , t h e p o r t i o n s p e c i f i c a l l y H h i g h l i g h t eb y t h e o p p o n e n t ss m e n t i o n e d e l o w : d i b i. I n d e e dr u l e o f l a w q u a t i n g n p r e d i c t a b i l ioy p a t e n t a b i l i t y ,p p l i e d n t h i s c a s e w o u l d , u tf a i , m e a nt h a t a n y n e w s a l t- i n c l u d i n t h o s es p e c i f i c a l l iy t e di n t h e 9 0 9 p a t e n ti t s e l f g s p , w o u l d b e s e p a r a t e l y a t e n t a b l es i m p l yb e c a u s eh e f o r m a t i o na n d p r o p e r t i e s f t o
e a c hs a l tm u s t b e v e r i f i e d h r o u g h e s t i n gT h i sc a n n o tb e t h e p r o p e rs t a n d a r d i n c e t t . s t h e e x p e c t a t i oo f s u c c e sn e e do n l yb e r e a s o n a b ln o t a b s o l u t eM e r c k , 7 4 F . 2 d t n e s . 8 a ( . 8 0 9 ;I n r e O . F a r r e l l8 5 3 f 2 D 8 9 4 , 9 0 3 F e d C i r .1 9 B B ) . ,
i i . R a t h e ro u r c o n c l u s i oh e r er e l i e d n t h e f a c tt h a t o n e s k i l l e dn t h e a r t w o u l dh a v eh a d , n o i
a r e a s O n a bee p e c t a t i oo f s u c c e sa t t h e t i m e t h e i n v e n t i o n a s m a d e , n d m e r e l y lx n s w a h a d t o v e r i f yt h a t e x p e c t a t i o n . e f i n d t h i s c a s ea n a l o g o uts t h e o p t i m i z a t i oo f a W o n r a n g eo r o t h e r v a r i a b l e i t h i n t h e c l a i m st h a t f l o w s f o r m t h e " n o r m a ld e s i r eo f w s c i e n t i s t s r a r t i s a n s o i m p r o v eu p o n w h a t i s a l r e a d vg e n e r a l l v n o w n " . I n r e o t k . ( g P e t e r s o n ,1 - 5 .3 d 1 3 2 5 ,1 3 3 0( F e d C i r .2 0 0 3 ) d e t e r m i n i nw h e r ei n a d i s c l o s es e t 3 F d o f p e r c e n t a g ea n g e s h e o p t i m u mc o m b i n a t i o n f p e r c e n t a g ei e s i n p r i m af a c i e r t o l o b v i o u s )I.n r e A l l e r ,2 2 OF . 2 d4 5 4 , 4 5 6( C . C . P . A . 5 5 ) , u r p r e d e c e s s o r u r t s e t 19 o co f o r t h t h e r u l e t h a t t h e d i s c o v e r v f a n o p t i m u mv a l u e o f a v a r i a b l e n a k n o w n o i p r o c e s is u s u a l l v b v i o u sS e ea l s oI n r e B o e s c h , 6 I T2 D 2 7 2 , 2 7 6( C . C . P . 1 9 8 0 ) A. s o . f ( " D i s c o v e ro f a n o p t i m u mv a l u eo f r e s u l te f f e c t i v e a r i a b l e n a k n o w n p r o c e s ss y v i i o r d i n a r i lw i t h i nt h e s k i l o f t h e a r t " ) . y l ( i i i )l t i s n o t i n v e n t i v e t o i s c o v e r t h e p t i m u mo r w o r k a b l e a n e e s y r o u t i n e x p e r i m e n t a t i o n . " d o r b e ( q u o t i n g l l o e r2 2 O . 2 d t 4 5 6 ) A F a ( i i i )T h u s ,w h i o l ep a t e n t a b i l i to f a n i n v e n t i o ns n o t n e g a t e d y t h e m a n n e ri n w h i c h i t w a s y i b y m a d e , T h ec o n v e r s ie e q u a l l yr u e :p a t e n t a b i l i its n o t i m p a r t e d h e r e ' t h e p r i o ra r t w o u l d " s t w h a v es u g g e s t etd o n e o f o r d i n a r y k i l li n t h e a r t t h a t t h i s p r o c e s s h o u l db e c a r r i e d u t a n d o s o w o u l d h a v ea r e a s o n a b l le k e l i h o o d f s u c c e s s .M e r c k ,8 7 4 F . 2 da t 8 0 9 ( q u o t i n g n r e D o w i I o " . C h e m C o . , 3 7 F . d 4 6 9 a 7 3 ( F e d C i r .1 9 B B ) . . 8 2 , ( l v )T h e o p p o n e n t s e f e r r e d o t h e p a r a8 . 4 2o f t h e i r r e p r e s e n t a t i o n a t , u n e x p e c t e d n eo f r t th ss i m p r o v e m e n tf p r o p e r t i e s ' h a s e ni n t e r p r e t eb y t h e H o n ' b l e o u r ti n t h e f o l l o w i n g t e r m s : d o be c 'Evidence o f u n e x p e c t e d e s u l t sc a n b e u s e d t o r e b u t a p r i m a f a c i e c a s e o f o b v i o u s n e s s r P e t e r s o n ,L 5 F . 3 d a 1 3 3 0 . 3 t ( [ W h e n n e x p e c t erd s u l t s r e u s e da s e v i d e n c o f n o n o b v i o u s n e sts ,e r e s u l t s u s tb e s h o w n u e e h m a p t o b e u n e x p e c t ec o m p a r e d i t h t h e c l o s e t r i o ra r t " ( q u o t i n g n r e B a x t e r r a v e n oL a b s .9 5 2 w I T l , d , F . 2 d B B 3 9 2( F e d C i r .1 9 9 L ) . 3 ,
10
Inviewofa||theaforementioneddiscussion,considerationofrep|yandargumentofthe arguments s t b y t h e a p p l i c a na n d o p p o n e n t s t a t e m e n t s ' s e a p p l i c a n t , x p e r te v i d e n c e u b m i t t e d Inc. i d e c i s i o n , , F e d e r C|i r c u i t sn P f i z e r , a a a n d E v i d e n c e n d r e | y i n go n t h e a b o v e - m e n t i o n e d concludethat the prior art as DecidedMarch 22, 2oo7\"I hereby (20061261"; Avotex Inc. to the person m af a n d i n v e n t i v e n e s sf o r d s o t i v a t i o n g f d i s c u s s ea b o v e o r e v a r u a t i no b v i o u s n e s s d o the results f the s e x p e c t a t i oo f s u c c e s" t o a r r i v ea t n r i s k i l l e dn t h e a r t a n d b r i n g s " e a s o n a b l e ( P o c )P M P A i t o f i m p r o v e m e no f p r o p e r t i e sn B l s a i i m p u g n e dn v e n t i o n n d t h e u n e x p e c t e d n e s s s s u c hF u m a r a t e a l t s f s b y t h e a p p l i c a n tw e r e e x p e c t e dr o m n o n c o n v e r s i oa s B p p Fa s e x p l a i n e d t o p r o v i d ea n y d a t a a n d i n t h e i m p u n g e d a s h a p p l i c a n tfs i l e d al o f p h a r m a c e u t i cs u b s t a n c e T . e andtheirexpert l s t v e r i f yt h e a p p l i c a n t 'c o u n s es t a t e m e n t s p e c i f i c a t i ow h i c hw a s r e q u i r e d o n r resultselatingto s o f i m p r o v e m e n to v e rt h e e x p e c t e d s e v i d e n c e t a t e m e hfto r u n e x p e c t e d n e s s o o i t ' s c o n v e r s i otn B P P F ' ) s t h e p r o p e r t i eo f B i s( P O CP M P A n of the impugned t h e o p p o n e n t h a t t h e c l a i m e dB P P F ( F . 2 . 1 0F u r t h e ri,t h a s b e e n s t a t e db y ) stated " o f " V I R E A D T' h e o p p o n e n th a s a l s o i in b e i n gm a r k e t e d n t h e b r a n dn a m e s applicatio zo07andyear o " v r R E A Di"n t h e r a s tq u a r t e ro f 7 % oa n dr L % d r o p i n s a r e s f that there was b 4 of exhibit provided y t i 2 0 0 6a s m e n t i o n e dh e o n p a g e1 2 tt e n d i n g 2 o o 7a s a g a i n sh e s a l e s n theapp|icant.ThisprovesthatBPPFdoesnothaveenhancedbeneficiaIattributes.
(F.2.11)Theopponentprovidedthedocument"ApprovedDraftLabelingofVired'Page3ofs " s Absorptiontates su p t h e h e a d i n g h a r m a c o k i n e t i c s ,b - h e a d i n g t d o c u m b n itt s t a t e s h a t u n d e r 2 5 %a n d i f r o m V i r e a di n f a s t e dp a t i e n t s s a p p r o x i m a t e l y ty T h e o r a rb i o a v a i r a b i r io f t e n o f o v i r opponentthen 40% following a high-fat meal' The ely 75%and approximately approximat (isopropyloxy of ,,antiretroviral and pharmacokinetics oral B Bis Efficacy to referred the article 11
A in Mice' Antimicrob gents m l c a r b o n y l o xm e t h y l )9 - ( 2 - p h o s p h o n y l e t h o x y p r o p ya)d e n i n e y o t s b y t h e a p p l i c a n td u r i n g h e h e a r i n g f " ; c h e m o t h e r a p1 9 9 8 J u l y4 2 ( 7 ) :1 5 6 8 - 1 5 7 3p r e s e n t e d y .,For bis (PoC) PMPA, the ora| WHICH oN PAGE L577 IE^CHESTHAT 2076lDe|11997 i dogs' o b i o a v a i l a b i liis e s t i m a t etd b e 2 0 %i n m i c ea n d 3 0 % n ty i B b y p r o v i d i n g P P Fs o n l y1 0 % ' e t T h eo p p o n e n t s t a t e d h a t t h e i n c r e a s i n b i o a v a i l a b i l i t a p t o E x p e r tE v i d e n c e a r a 1 5 ' 1 - n d a p p l i c a n t s i a o l F . 2 . L 2 l T h e p p o n e n t s l l e g a t i o nn r e f e r e n c e t o f a b o u t3 t i m e s b e t w e e n h e P K A r e p l yp a r aB . 4 Lt h a t t h e r e s h o u l db e . am i n i m u md i f f e r e n c e i w h e n t h e D r u g s u b s t a n c es a v a l u e o f t h e g r o u p a n d t h a t o f i t ' s c o u n t e ri o n e s p e c i a l l y this was nowhereincorporated L weak acidor base(Exhibit page 427lastsentence) particularly a of inthesoecification impugned pplication' u n i t si n t h e P k av a l u e "w h i c h e t a ( F . 2 . 1 3 ) T ho p p o n e n t l s oa l l e g e dh a t t h e d i f f e r e n c o f a b o u t3 e t a h a s d e r i b e r a t e r yv o i d e d h e f u r t h e r a r o n eh a s b e e n q u o t e db y t h e E x p e r ta n d t h e a p p r i c a n t m " o c c a s i o n a l le x c e p t i o n s a y b e f o u n d y, S t a t e m e n to n p a g e 2 c o l u m n2 w h i c h g o t o s a y s i b e i n g s m a l l e rd i f f e r e n c en t h e p K a t d s wherea salt has an acceptabletability espite here a t i n t h e p r e s e n c a s e n d t h u st h e s t su v a l u e . , o p p o n e n t b m i t sh a t t h i s w a st h e p r e c i s e i t u a t i o n c i s e l e c t i o o f t h e F u m a r a t es a n o b v i o u s h o i c e ' n e s h w i t h r e s p e ctto p a r a g r a p 1 5 ' 9o f a p p l i c a n te x p e r t v i d e n c e a l t . 2 . L 4 ) t h eo p p o n e n t s l l e g a t i o n t i ( P o c ) P M P At, w a s s t a t e d h a t t h e s ea r e n h w h e r et h e e x p e r th a sd i s c u s s etd e d i m e r i s a t i oo f B i s t w S reasoning' imilarly ith regard o w m e r e s t a t e m e n t s h i c h a r e b e r e f to f d a t a a n d s c i e n t i f i c i p r o v i d e d n s u p p o r to f t h e e n h a n c e d t l p a r a g r a m- 5 . L 1 i-t, i s s u b m i t t e d h a t n o d a t a h a s b e e n t c l a i m e db y t h e a p p l i c a n a n d m e r e l y s o c l i n i c a s a f e t va n d e f f i c a c y f t h e " F u m a r a t e a l t " a s l c a n ys c i e n t i f io r t e c h n i c arle a s o n i n g ' w s in s u p p o r t e d t h e f o r m o f s t a t e m e n tb y t h e e x p e r t i t h o u t w h i c h c a n o n l y b e p r o v e db y l c M e r e s t a t e m e n t s a n n o t p r o v e a v i t a l t e c h n i c aa d v a n t a g e c a n n o tp r o c e e dm e r e l yo n t h e b a s i so f o d e x p e r i m e n t a la t a i n t h e a b s e n c e f w h i c h t h e o n e t l d o u b t w i t h r e g a r d o h i se x p e r t i s e w s t a t e m e n to f t h e e x p e r t h o o n t h e f a c eo f t h e d o c u m e n t s s d i n t h e c o n c e r n e a r e ao f t e c h n o l o g y ' p a g e7 l i n e s 1 0 t o 1 6 o f t h e c o m p l e t e a ( F . 2 . 1 5T h e o p p b n e n t s l s o d r e w t h e a t t e n t i o nt o ) s p e c i f i c a t i o n o f t h e i m p u g n e d a p p | i c a t i o n w h e r e i n a d m i t t e d | y a t , , D o s a g e s d s u i t a b l e d m i n i s t r a t i orn u t e s o b e s ta t t a c k h e s i t eo f i n f e c t i o n r e w e l l k n o w n t o a an
t2
i t ( F . 3 )n o t p a t e n t a b l e / s 3 ( d ) : l t h a s b e e n o b s e r v e d h a t t h e o p p o n e n ta l l e g e sm p u g n e d U k ) B f i n v e n t i o na l l sU / S 3 ( d ) a s t h e b a s i cc o m p o u n d I S( P O C P M P Ai s a l r e a d y n o w nb e f o r et h e 'the h . i m p u g n e da p p l i c a t i o nT h e i m p u g n e da p p l i c a t i o n a s p r o v i d e dt h e prioritydate of " o F u m a r a t s a l t s f t h e B i s( p o c ) p M p Aw h i c hi s a s a l to f k n o w ns u b s t a n c eu n d e rt h e d e f i n i t i o n e s t o f s e c 3 ( d ) .T h e a p p l i c a nh a d t h e d u t y t o p r o v et h a t t h e F u m a r a t e a l t s h o w e ds i g n i f i c a n t to with regard efficacy' in improvements properties B H 7 I r e l yo n t h e j u d g m e n td a t e d0 6 - 0 8 - 2 0 0o f t h e H o n ' b l e i g hC o u r to f M a d r a si n N o v a r t i s S h s U O I c a s e w h e r e t h e e f f i c a c yi n r l o t h e p h a r m a c e u t i c a lu b s t a n c e a v e b e e n d e f i n e da s c t h e r a p e u t i e f f i c a c yw h i c h m a y b e p r o v e db y p r o v i d i n g l i n i c atlr a i l so f t h e n e w l yd e v e l o p e d c n s ub s t a c e . t d t T h er e l e v a np a r to f t h e a b o v es a i dj u d g m e n i s r e p r o d u c eb e l o w : of that the very discovery a newform of only declores the "As we understand omended section, of which does not resultin the enhoncement the known efficocyof that o known substonce of Thepositionthereforeis,if the discovery a new will substonce, notbe treotedas on invention.
l3
should then the potent opplicotion mustbe treatedas an invention, form of o known substance effect"" ln other words the has so show thot the substonce discovered a better therapeutic effect of the drugfor which is potent oppticont definitetyaware as to whot is the "Theropeutic between the theropeuticeffect of the he had alreadygot o potent and what is the difference creotesa explonotion of for potented drug and thedrug in respect whichpotent is osked .-. The would be deemedto be the some substonce of deeming fiction thot all derivotives a known with regordto efficocy' in it unless differsignificontly properties substonce t d e p i c ta n y c l i n i c atlr i a l r e s u l t so a n t I t h a sb e e no b s e r v e dh a t t h e i m p u g n e d p p l i c a t i od o e sn o t i B ( P o c )P M P A n t e r m so f s f n p r o v e t l r a t t h e e w l y f o r m e du m a r a t e a l ti s m o r ee f f i c a c i o u s t h a ni s do in improvements the properties, as in is whatever shown details the so-called effects. therapeutic Id t d t h ea b o v e i s c u s s eh o l d h a t o if n n o ta m o u ntto a n e n h a n c e m eo ftt h e r a p e u tec f e c tI.n t h e l i g h t f a l l n 3 ( d )a n dh e n c e o tP a t e n t a b l e ' r fn u d n n t h ei n v e n t i oa sc l a i m eid t h ei m p u g n ea p p l i c a t i oa l l s n d e s e c t i o n I discussion concludethat the (G) CONCLLISION: Finally in view of tlic abovemcntionecl oi tJ/S is No. ol'theapplication 896/Dell2o02 no1Partentable l1(-i)l in as invention claimecj clainrs clainlsalsolalls tJ/s 3 (d). Step.'l'hc of as beingclevoid ir.rvct-ttive Act the patents (As a.r.rer.rdecl) No' on to grantthe patent applicahle I (H)O R D E R:-1n the liglit of thc abovediscussionreluse No 896/Del/2002. orderfbr cost.
Dated: 30/07/2009
14